help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orloff, J. J.
Right arrow Articles by Isales, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orloff, J. J.
Right arrow Articles by Isales, C. M.

Endocrinology, Vol 137, 5376-5385, Copyright © 1996 by Endocrine Society


ARTICLES

A midregion parathyroid hormone-related peptide mobilizes cytosolic calcium and stimulates formation of inositol trisphosphate in a squamous carcinoma cell line

JJ Orloff, MB Ganz, MH Nathanson, MS Moyer, Y Kats, M Mitnick, A Behal, J Gasalla-Herraiz and CM Isales
Division of Endocrinology and Metabolism, Veterans Affairs Connecticut Healthcare System, West Haven 06516, USA.

A midregion fragment of PTH-related protein (PTHrP), which is intensively conserved across species, has been identified as a secretory product of several different cell types, including keratinocytes and squamous carcinomas. As recent data suggest that a midregion PTHrP fragment may be biologically active, we hypothesized that midregion PTHrPs interact with unique cell surface receptors that mediate autocrine or paracrine action. Dose-dependent transient elevations in intracellular calcium ([Ca2-]i) were observed in fura-2- loaded SqCC/Y1 squamous carcinoma cells exposed to human (h) PTHrP-(67- 86)NH2, [Tyr36]hPTHrP-(1-36)NH2, and hPTHrP-(1-141) at concentrations ranging from 1 pM to 1 microM. The effects of maximal stimulatory concentrations of [Tyr36]PTHrP-(1-36)NH2 and PTHrP-(67-86)NH2 on [Ca2+]i were additive. The inhibitory PTH analog, [D-Trp12,Tyr34]bovine PTH-(7-34)NH2, attenuated the [Ca2+]i response to [Tyr36]hPTHrP-(1- 36)NH2, but not that to PTHrP-(67-86)NH2. These data suggest that PTHrP- (67-86)NH2 activates a different receptor pathway in SqCC/Y1 cells from the one activated by [Tyr36]hPTHrP-(1-36)NH2. Radiolabeled PTHrP-(67- 86)NH2 did not bind to SqCC/Y1 cells, and PTHrP-(67-86)NH2 did not compete for binding of 125I-labeled [Tyr36]PTHrP-(1-36)NH2 to PTH/PTHrP receptors on SaOS-2 osteosarcoma cells. Activation of the phospholipase C pathway by PTHrP-(67-86)NH2 was confirmed by exposing SqCC/Y1 cells to peptide for 1 min and measuring the accumulation of inositol trisphosphates. PTHrP-(67-86)NH2 treatment (100 nM) resulted in maximal stimulation of inositol trisphosphates of 3.1 +/- 0.1-fold over the control value, with an EC50 of 1.5 +/- 1.2 nm. In contrast, PTHrP-(67- 86)NH2 (0.1 nM to 1 microM) did not stimulate adenylyl cyclase in SqCC/Y1 cells despite vigorous stimulation of cAMP formation by isoproterenol (1 microM) to 66-fold over the basal value. To determine whether messenger RNA (mRNA) prepared from SqCC/Y1 cells would direct the translation of a receptor protein that mediated a [Ca2+]i response to PTHrP-(67-86)NH2, we performed expression studies in Xenopus oocytes. Fluo-3 fluorescence in Xenopus oocytes expressing SqCC/Y1 mRNA was visualized by confocal video microscopy after exposure to 1 microM PTHrP-(67-86)NH2. Clear increases in [Ca2+]i were detected in mRNA- injected, but not in sham-injected, oocytes. Finally, we examined the effect of PTHrP-(67-86)NH2 treatment on fibronectin secretion from SqCC/YN1 cells. A significant 3.5-fold increase in fibronectin secretion into conditioned medium was observed when SqCC/Y1 cells were exposed to 100 nM PTHrP-(67-86)NH2, and this effect was dose dependent, with an EC50 of 0.1 nM. We conclude that PTHrP-(67-86)NH2 activates phospholipase C-dependent pathways in SqCC/Y1 cells through a receptor distinct from that activated by PTHrP-(1-36) in the same cells. As a midregion secretory fragment of PTHrP has been partially purified from several different cell types, this receptor may have broad biological significance.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Dittmer, M. Vetter, D. Schunke, P. N. Span, F. Sweep, C. Thomssen, and J. Dittmer
Parathyroid Hormone-related Protein Regulates Tumor-relevant Genes in Breast Cancer Cells
J. Biol. Chem., May 26, 2006; 281(21): 14563 - 14572.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. H. Hastings, R. A. Quintana, R. Sandoval, D. Duey, Y. Rascon, D. W. Burton, and L. J. Deftos
Proapoptotic Effects of Parathyroid Hormone-Related Protein in Type II Pneumocytes
Am. J. Respir. Cell Mol. Biol., December 1, 2003; 29(6): 733 - 742.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Luparello, R. Sirchia, and D. Pupello
PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression
J. Cell Sci., June 15, 2003; 116(12): 2421 - 2430.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Pizzi, J. Gladu, L. Carpio, D. Miao, D. Goltzman, and S. A. Rabbani
Androgen Regulation of Parathyroid Hormone-Related Peptide Production in Human Prostate Cancer Cells
Endocrinology, March 1, 2003; 144(3): 858 - 867.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. A. Tovar Sepulveda, X. Shen, and M. Falzon
Intracrine PTHrP Protects against Serum Starvation-Induced Apoptosis and Regulates the Cell Cycle in MCF-7 Breast Cancer Cells
Endocrinology, February 1, 2002; 143(2): 596 - 606.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. MASSFELDER, N. TAESCH, N. ENDLICH, A. EICHINGER, B. ESCANDE, K. ENDLICH, M. BARTHELMEBS, and J.-J. HELWIG
Paradoxical actions of exogenous and endogenous parathyroid hormone-related protein on renal vascular smooth muscle cell proliferation: reversion in the SHR model of genetic hypertension
FASEB J, March 1, 2001; 15(3): 707 - 718.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Slominski and J. Wortsman
Neuroendocrinology of the Skin
Endocr. Rev., October 1, 2000; 21(5): 457 - 487.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
R. J. Bollag, Q. Zhong, P. Phillips, L. Min, L. Zhong, R. Cameron, A. L. Mulloy, H. Rasmussen, F. Qin, K. H. Ding, et al.
Osteoblast-Derived Cells Express Functional Glucose-Dependent Insulinotropic Peptide Receptors
Endocrinology, March 1, 2000; 141(3): 1228 - 1235.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Qian, J. N. Lorenz, S. Maeda, R. L. Sutliff, C. Weber, T. Nakayama, M. C. Colbert, R. J. Paul, J. A. Fagin, and T. L. Clemens
Reduced Blood Pressure and Increased Sensitivity of the Vasculature to Parathyroid Hormone-Related Protein (PTHrP) in Transgenic Mice Overexpressing the PTH/PTHrP Receptor in Vascular Smooth Muscle
Endocrinology, April 1, 1999; 140(4): 1826 - 1833.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
B. Lanske, P. Divieti, C. S. Kovacs, A. Pirro, W. J. Landis, S. M. Krane, F. R. Bringhurst, and H. M. Kronenberg
The Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Mediates Actions of Both Ligands in Murine Bone
Endocrinology, December 1, 1998; 139(12): 5194 - 5204.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Massfelder, P. Dann, T. L. Wu, R. Vasavada, J.-J. Helwig, and A. F. Stewart
Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: A critical role for nuclear targeting
PNAS, December 9, 1997; 94(25): 13630 - 13635.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society